CVRX

SEC source: 0001415889-22-011857 · form4-11302022_101152.xml · nonDerivative · entry 3

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,400

F2 · price: Reflects the weighted average price of 600 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on November 28, 2022 with sale prices ranging from $12.52 to $12.53 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-22-011857 · form4-11302022_101152.xml · nonDerivative · entry 2

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · price: Reflects the weighted average price of 4,000 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on November 28, 2022 with sale prices ranging from $11.51 to $12.49 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-22-011857 · form4-11302022_101152.xml · nonDerivative · entry 1

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-008281 · form4-08042022_040817.xml · derivative · entry 1

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-08-01

F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

SEC source: 0001415889-22-008288 · form4-08042022_050817.xml · derivative · entry 1

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-08-01

F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

SEC source: 0001415889-22-008283 · form4-08042022_040814.xml · derivative · entry 1

BRUHN-DING DEAN · CIK 0001869525 · VP OF REG. AFFAIRS AND QA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2032-08-01

F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

SEC source: 0001415889-22-008287 · form4-08042022_050857.xml · derivative · entry 1

Galle Liz · CIK 0001869353 · VP OF GLOBAL CLINICAL RESEARCH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2032-08-01

F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

SEC source: 0001415889-22-008282 · form4-08042022_040854.xml · derivative · entry 1

Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-08-01

F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

SEC source: 0001415889-22-008280 · form4-08042022_040810.xml · derivative · entry 1

Yared Nadim · CIK 0001554977 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2032-08-01

F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter.

SEC source: 0001415889-22-006370 · form4-06092022_010602.xml · derivative · entry 1

NEHRA JOHN M · CIK 0001005547 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,985

Underlying: Common Stock · 26,985 shares

Expires 2032-06-06

F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders.

SEC source: 0001415889-22-006374 · form4-06092022_010652.xml · derivative · entry 1

SHADAN MARTHA · CIK 0001871700 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,985

Underlying: Common Stock · 26,985 shares

Expires 2032-06-06

F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders.

SEC source: 0001415889-22-006363 · form4-06092022_010657.xml · derivative · entry 1

SLATTERY JOSEPH P · CIK 0001246530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,985

Underlying: Common Stock · 26,985 shares

Expires 2032-06-06

F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders.

SEC source: 0001209191-22-035472 · doc4.xml · derivative · entry 1

Behbahani Ali · CIK 0001613867 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,985

Underlying: Common Stock · 26,985 shares

Expires 2032-06-06

F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders.

SEC source: 0001415889-22-006365 · form4-06092022_010640.xml · derivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,985

Underlying: Common Stock · 26,985 shares

Expires 2032-06-06

F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders.

SEC source: 0001415889-22-006380 · form4-06092022_010633.xml · derivative · entry 1

Jain Mudit K. · CIK 0001584404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,985

Underlying: Common Stock · 26,985 shares

Expires 2032-06-06

F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 8

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 527

Underlying: Common Stock · 2,633 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 7

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,160 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 6

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,528 shares

Expires 2026-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 5

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,264 shares

Expires 2025-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 4

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 3

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 2

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,792

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 1

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-22-019805 · doc4.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,711,355

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.02 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-019287 · doc4.xml · nonDerivative · entry 3

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,703,285

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.01 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-019287 · doc4.xml · nonDerivative · entry 2

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,698,853

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.99 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-019287 · doc4.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,685,466

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.005 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-016823 · doc4.xml · nonDerivative · entry 3

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,674,490

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-016823 · doc4.xml · nonDerivative · entry 2

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,670,498

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.91 to $6.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-016823 · doc4.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,644,995

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.95 to $6.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-016135 · doc4.xml · nonDerivative · entry 2

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,612,186

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.85 to $6.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F1 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-016135 · doc4.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,570,198

F1 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0001415889-22-004278 · form4-04272022_010433.xml · derivative · entry 3

Yared Nadim · CIK 0001554977 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,055

Underlying: Common Stock · 6,059 shares

Expires 2025-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable.

SEC source: 0001415889-22-004278 · form4-04272022_010433.xml · nonDerivative · entry 1

Yared Nadim · CIK 0001554977 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · derivative · entry 12

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,264 shares

Expires 2025-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · derivative · entry 11

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,792 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · derivative · entry 10

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,221 shares

Expires 2023-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · derivative · entry 9

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 702

Underlying: Common Stock · 2,584 shares

Expires 2025-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · derivative · entry 8

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 685

Underlying: Common Stock · 1,590 shares

Expires 2025-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · nonDerivative · entry 5

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · nonDerivative · entry 4

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,637

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · nonDerivative · entry 3

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · nonDerivative · entry 2

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-004253 · form4-04262022_010427.xml · nonDerivative · entry 1

BRINTNALL JOHN · CIK 0001869656 · CHIEF STRATEGY OFFICER AND SEC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-22-001898 · edgar.xml · nonDerivative · entry 1

Jain Mudit K. · CIK 0001584404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,400

F1 · price: Reflects the weighted average price of 600 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on February 28, 2022 with purchase prices ranging from $9.02 to $9.0899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0000899243-22-008108 · doc4.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,570,098

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-007418 · doc4.xml · nonDerivative · entry 3

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,566,698

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $8.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-007418 · doc4.xml · nonDerivative · entry 2

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,528,498

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $8.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0000899243-22-007418 · doc4.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,488,490

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.54 to $8.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0001179110-22-001003 · edgar.xml · derivative · entry 26

BRUHN-DING DEAN · CIK 0001869525 · VP of Reg. Affairs and QA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,048

Underlying: Common Stock · 5,158 shares

Expires 2026-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.